SAN FRANCISCO, June 19, 2017 /PRNewswire/ --
The global radiodermatitis market is expectedto reach USD 442.1 million by 2025, according to a new report by Grand View Research, Inc. The global radiodermatitis market is expected to grow at an unprecedented rate owing to the growing prevalence of cancer patients
(Logo: http://photos.prnewswire.com/prnh/20160524/371361LOGO )
In addition, increasing R&D activities in the area of life sciences is presumed to be one of the significant factors contributing toward growth of this market. For instance, in December 2016, Mölnlycke Health Care AB entered into a licensing agreement with a Texas-based R&D company Rochal Industries. This agreement was carried out to reinforce its position as a prevention solutions firm. In addition, they have signed a joint agreement to enhance their R&D capabilities and commercialize new patented technological platforms.Other factors such as escalating number of product launches with respect to radiodermatitis treatment and increasing demand for these products are expected to boost the overall market growth.
Browse full research report with TOC on "Radiodermatitis Market Analysis By Product (Topical, Corticosteroids, Hydrophilic Creams, Antibiotics, Dressings, Hydrogel & Hydrocolloid, No Sting Barrier Film, Silicone Coated), By Distribution Channel, And Segment Forecasts, 2014 - 2025" at: http://www.grandviewresearch.com/industry-analysis/radiodermatitis-market
Further key findings from the report suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global radiodermatitis market on the basis of product, distribution channel, and region:
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: +1-888-202-9519 Email: [email protected]
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...
Colorectal cancer is a cancer that starts in the colon or the rectum. Colo-rectal cancer is the ...View All